Nucleophosmin (NPM1) mutations in acute myeloid leukemia: An ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies

Journal of Molecular Diagnostics

Volumn 10, Issue 3, 2008, Pages 198-202

  Wertheim, Gerald ^a   Bagg, Adam ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW CELL; CHROMOSOME TRANSLOCATION; CYTOCHEMISTRY; CYTOGENETICS; FLOW CYTOMETRY; GENE FREQUENCY; GENE INSERTION SEQUENCE; GENE MUTATION; IMMUNOPHENOTYPING; KARYOTYPE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NOTE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 43749118762     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2008.080019     Document Type: Note

References (30)

1. JC Byrd K Mrozek RK Dodge AJ Carroll CG Edwards DC Arthur MJ Pettenati SR Patil KW Rao MS Watson PR Koduru JO Moore RM Stone RJ Mayer EJ Feldman FR Davey CA Schiffer RA Larson CD Bloomfield Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood 100 2002 4325 4336
2. D Grimwade H Walker F Oliver K Wheatley C Harrison G Harrison J Rees I Hann R Stevens A Burnett A Goldstone The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties Blood 92 1998 2322 2333
3. ML Slovak KJ Kopecky PA Cassileth DH Harrington KS Theil A Mohamed E Paietta CL Willman DR Head JM Rowe SJ Forman FR Appelbaum Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study Blood 96 2000 4075 4083
4. K Wheatley AK Burnett AH Goldstone RG Gray IM Hann CJ Harrison JK Rees RF Stevens H Walker A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties Br J Haematol 107 1999 69 79
5. E Estey H Dohner Acute myeloid leukaemia Lancet 368 2006 1894 1907
6. L Kelly J Clark DG Gilliland Comprehensive genotypic analysis of leukemia: clinical and therapeutic implications Curr Opin Oncol 14 2002 10 18
7. K Mrozek CD Bloomfield Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia Hematology Am Soc Hematol Educ Program 2006 169 177
8. D Small FLT3 mutations: biology and treatment Hematology Am Soc Hematol Educ Program 2006 178 184
9. LM Kelly DG Gilliland Genetics of myeloid leukemias Annu Rev Genomics Hum Genet 3 2002 179 198
10. C Callens S Chevret JM Cayuela B Cassinat E Raffoux S de Botton X Thomas A Guerci N Fegueux A Pigneux AM Stoppa T Lamy F Rigal-Huguet A Vekhoff S Meyer-Monard A Ferrand M Sanz C Chomienne P Fenaux H Dombret Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group Leukemia 19 2005 1153 1160
11. A Lasa MT Carricondo MJ Carnicer G Perea A Aventin JF Nomdedeu A new D816 c-KIT gene mutation in refractory AML1-ETO leukemia Haematologica 91 2006 1283 1284
12. B Falini C Mecucci E Tiacci M Alcalay R Rosati L Pasqualucci R La Starza D Diverio E Colombo A Santucci B Bigerna R Pacini A Pucciarini A Liso M Vignetti P Fazi N Meani V Pettirossi G Saglio F Mandelli F Lo-Coco PG Pelicci MF Martelli Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype N Engl J Med 352 2005 254 266
13. K Cheng S Grisendi JG Clohessy S Majid R Bernardi P Sportoletti PP Pandolfi The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: arf inactivation and induction of cellular senescence Oncogene 26 2007 7391 7400
14. B Falini MP Martelli N Bolli R Bonasso E Ghia MT Pallotta D Diverio I Nicoletti R Pacini A Tabarrini BV Galletti R Mannucci G Roti R Rosati G Specchia A Liso E Tiacci M Alcalay L Luzi S Volorio L Bernard A Guarini S Amadori F Mandelli F Pane F Lo-Coco G Saglio PG Pelicci MF Martelli C Mecucci Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia Blood 108 2006 1999 2005
15. C Thiede S Koch E Creutzig C Steudel T Illmer M Schaich G Ehninger Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) Blood 107 2006 4011 4020
16. B Falini I Nicoletti MF Martelli C Mecucci Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features Blood 109 2007 874 885
17. K Dohner RF Schlenk M Habdank C Scholl FG Rucker A Corbacioglu L Bullinger S Frohling H Dohner Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations Blood 106 2005 3740 3746
18. RE Gale C Green C Allen AJ Mead AK Burnett RK Hills DC Linch Medical Research Council Adult Leukaemia Working Party The impact of FLT3 internal tandem duplication mutant level, number, size and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia Blood 111 2008 2776 2784
19. RE Gallagher Dueling mutations in normal karyotype AML Blood 106 2005 3681 3682
20. M Palmisano T Grafone E Ottaviani N Testoni M Baccarani G Martinelli NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia Haematologica 92 2007 1268 1269
21. WC Chou JL Tang SJ Wu W Tsay M Yao SY Huang KC Huang CY Chen CF Huang HF Tien Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations Leukemia 21 2007 998 1004
22. P Szankasi M Jama DW Bahler A new DNA-based test for detection of nucleophosmin exon 12 mutations by capillary electrophoresis J Mol Diagn 10 2008 236 243
23. T Ottone E Ammatuna S Lavorgna NI Noguera F Buccisano A Venditti L Gianni M Postorino G Federici S Amadori F Lo Coco An allele-specific RT-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia J Mol Diagn 10 2008 212 216
24. S Scholl LO Mugge O Landt IF Loncarevic C Kunert JH Clement K Hoffken Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia Leuk Res 31 2007 1205 1211
25. G Roti R Rosati R Bonasso P Gorello D Diverio MF Martelli B Falini C Mecucci Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemia J Mol Diagn 8 2006 254 259
26. C Thiede E Creutzig T Illmer M Schaich V Heise G Ehninger O Landt Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR clamping Leukemia 20 2006 1897 1899
27. P Gorello G Cazzaniga F Alberti MG Dell'Oro E Gottardi G Specchia G Roti R Rosati MF Martelli D Diverio F Lo Coco A Biondi G Saglio C Mecucci B Falini Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations Leukemia 20 2006 1103 1108
28. T Hughes M Deininger A Hochhaus S Branford J Radich J Kaeda M Baccarani J Cortes NC Cross BJ Druker J Gabert D Grimwade R Hehlmann S Kamel-Reid JH Lipton J Longtine G Martinelli G Saglio S Soverini W Stock JM Goldman Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results Blood 108 2006 28 37
29. NI Noguera E Ammatuna D Zangrilli S Lavorgna M Divona F Buccisano S Amadori C Mecucci B Falini F Lo-Coco Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia Leukemia 19 2005 1479 1482
30. M Salto-Tellez SG Shelat B Benoit H Rennert M Carroll DG Leonard P Nowell A Bagg Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice J Mol Diagn 5 2003 231 236